Latest News from: Johns Hopkins Medicine

Filters close
Newswise: Clues Found Regarding Tumor Suppressor Gene’s Breast Cancer Activity
Released: 8-Dec-2022 10:00 AM EST
Clues Found Regarding Tumor Suppressor Gene’s Breast Cancer Activity
Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress formation of breast cancers.

Newswise:Video Embedded how-does-a-cell-move-pull-the-plug-on-the-electrical-charge-on-the-inner-side-of-its-membrane-say-scientists
VIDEO
Released: 8-Dec-2022 9:00 AM EST
How Does a Cell Move? ‘Pull the Plug’ on the Electrical Charge on the Inner Side of Its Membrane, Say Scientists
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine say that a key to cellular movement is to regulate the electrical charge on the interior side of the cell membrane, potentially paving the way for understanding cancer, immune cell and other types of cell motion. 

Newswise: Household Air Cleaners Improve Heart Health Among Individuals with COPD, Researchers Find
Released: 5-Dec-2022 10:00 AM EST
Household Air Cleaners Improve Heart Health Among Individuals with COPD, Researchers Find
Johns Hopkins Medicine

A six-month study led by Johns Hopkins Medicine researchers concludes that the use of portable home air purifiers can improve some markers of cardiovascular health in people with chronic obstructive pulmonary disease, or COPD

Newswise: 'Tis The Season to Focus on Your Mental Health
Released: 5-Dec-2022 9:00 AM EST
'Tis The Season to Focus on Your Mental Health
Johns Hopkins Medicine

Johns Hopkins Medicine experts can provide tips for managing your mental health amid the bustle of the holiday season.

Newswise: Johns Hopkins Researchers Generate Lab-Grown Human Tissue Model for Food Tube Cancer
Released: 1-Dec-2022 9:00 AM EST
Johns Hopkins Researchers Generate Lab-Grown Human Tissue Model for Food Tube Cancer
Johns Hopkins Medicine

Researchers discover that dual knockout of genes in organoids grown from human tissue generates a model of and potential therapeutic target for gastroesophageal junction cancer

Newswise: One of Two Widely Used Macular Degeneration Drugs Outperforming Other at Weaning Patients off Treatment at One Year, Preliminary Study Shows
Released: 30-Nov-2022 1:30 PM EST
One of Two Widely Used Macular Degeneration Drugs Outperforming Other at Weaning Patients off Treatment at One Year, Preliminary Study Shows
Johns Hopkins Medicine

A pilot, “look-back” study of information about 106 patients with “wet” age-related macular degeneration (AMD) treated at the Wilmer Eye Institute at Johns Hopkins Medicine has revealed that nearly half of patients treated with aflibercept could safely stop eye injection therapy after one year without further vision loss.

Newswise: Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Released: 29-Nov-2022 5:25 PM EST
Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Johns Hopkins Medicine

Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.

Newswise: ‘You can always make a change’: 15-Year-Old Johns Hopkins Patient with Type 2 Diabetes Thrives Almost 2 Years After Diagnosis
Released: 28-Nov-2022 3:05 PM EST
‘You can always make a change’: 15-Year-Old Johns Hopkins Patient with Type 2 Diabetes Thrives Almost 2 Years After Diagnosis
Johns Hopkins Medicine

November is National Diabetes Awareness Month. Youth onset type 2 diabetes is rising worldwide, and a recent study by researchers at Johns Hopkins Children’s Center, published in the Journal of Pediatrics, documented a steep rise in new diagnoses of type 2 diabetes among children during the early part of the COVID-19 pandemic

Newswise: Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial Infections
Released: 21-Nov-2022 10:00 AM EST
Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial Infections
Johns Hopkins Medicine

PCORI funding will support trial to see if early transition to oral antibiotic therapy from intravenous administration improves outcomes for patients with gram-negative bloodstream infections

Newswise: Novel AI Blood Test Detects Liver Cancer
17-Nov-2022 2:00 PM EST
Novel AI Blood Test Detects Liver Cancer
Johns Hopkins Medicine

A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.

Newswise: Wearable Activity Trackers Can Be Used to Determine Health Metrics That Could Support Clinical Care
Released: 17-Nov-2022 12:00 PM EST
Wearable Activity Trackers Can Be Used to Determine Health Metrics That Could Support Clinical Care
Johns Hopkins Medicine

A new Johns Hopkins study shows that data gathered from wearable activity trackers can be used to obtain several metrics associated with the user’s general physical health and cardiovascular health status.

Newswise: Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed
Released: 16-Nov-2022 4:30 PM EST
Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed
Johns Hopkins Medicine

Newly published study in mice show augmented drug eliminates cancer cells without causing toxicity.

Newswise: Machine Learning Can Help Predict Patient Response to Cancer Immunotherapy
Released: 16-Nov-2022 10:00 AM EST
Machine Learning Can Help Predict Patient Response to Cancer Immunotherapy
Johns Hopkins Medicine

In a small study, Johns Hopkins Kimmel Cancer Center researchers successfully trained a machine learning algorithm to predict, in hindsight, which patients with melanoma would respond to treatment and which would not respond.

   
Newswise: Perspective: Audio Phone Visits with Medical Providers Remain Crucial Links to Delivering Equitable Health Care, Say Johns Hopkins Medicine Experts
Released: 14-Nov-2022 9:00 AM EST
Perspective: Audio Phone Visits with Medical Providers Remain Crucial Links to Delivering Equitable Health Care, Say Johns Hopkins Medicine Experts
Johns Hopkins Medicine

Writing in the Nov. 17 issue of the New England Journal of Medicine, two telemedicine experts and a historian at Johns Hopkins Medicine say audio-only telephone visits are an essential link to health care providers for patients without access to video visit options.

Newswise: Johns Hopkins Presents Initial Design of Building Named in Honor of Henrietta Lacks to Baltimore’s Urban Design and Architecture Advisory Panel
Released: 10-Nov-2022 1:05 PM EST
Johns Hopkins Presents Initial Design of Building Named in Honor of Henrietta Lacks to Baltimore’s Urban Design and Architecture Advisory Panel
Johns Hopkins Medicine

Johns Hopkins University and Johns Hopkins Medicine today presented the initial design plans for the on-campus building project named in honor of Henrietta Lacks, the Baltimore County woman whose cells have advanced medicine around the world, during an Urban Design and Architecture Advisory Panel meeting for Baltimore City Planning.

   
Newswise: Extracellular Viscosity Linked to Cancer Spread
2-Nov-2022 9:00 AM EDT
Extracellular Viscosity Linked to Cancer Spread
Johns Hopkins Medicine

New research findings show how higher viscosity, or resistance to flow, of the extracellular fluid that surrounds cells enables cancer cells to migrate more rapidly from a primary tumor to other sites in the body.

Newswise: Study Identifies Potential New Treatment Target for Sleep Apnea
Released: 31-Oct-2022 10:00 AM EDT
Study Identifies Potential New Treatment Target for Sleep Apnea
Johns Hopkins Medicine

In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people.

Newswise: Proof-of-Concept Study Advances Potential New Way to Deliver Gene Therapy
Released: 27-Oct-2022 1:30 PM EDT
Proof-of-Concept Study Advances Potential New Way to Deliver Gene Therapy
Johns Hopkins Medicine

Johns Hopkins Medicine researchers say they have successfully used a cell’s natural process for making proteins to “slide” genetic instructions into a cell and produce critical proteins missing from those cells.

Newswise: Neuroimaging Study Reveals Functional and Structural Brain Abnormalities in People with Post-Treatment Lyme Disease
Released: 26-Oct-2022 2:40 PM EDT
Neuroimaging Study Reveals Functional and Structural Brain Abnormalities in People with Post-Treatment Lyme Disease
Johns Hopkins Medicine

In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the “white matter” and other brain tissue physiology of those with post-treatment Lyme disease, a condition affecting 10% to 20% of the nearly half a million Americans who contract Lyme disease annually.

Newswise: Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine
Released: 19-Oct-2022 12:05 PM EDT
Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine
Johns Hopkins Medicine

The annual influenza (flu) season — which typically lasts from October to April in the United States — is upon us. Johns Hopkins Medicine experts will be available throughout the 2022–23 season for interviews about this year’s flu virus and flu vaccine, as well as other respiratory illnesses, such as COVID-19 and monkeypox.

Newswise: Can Obesity and Stress Influence Appetite? New Johns Hopkins Study Shows It’s All In Your Head
Released: 19-Oct-2022 9:00 AM EDT
Can Obesity and Stress Influence Appetite? New Johns Hopkins Study Shows It’s All In Your Head
Johns Hopkins Medicine

In a series of experiments using functional magnetic resonance imaging (fMRI) to measure brain activity across networks in the brain, Johns Hopkins Medicine researchers looked at how stress might increase appetite in obese and lean adults.

Newswise: Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Released: 13-Oct-2022 8:00 AM EDT
Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Johns Hopkins Medicine

It’s that time of year: costumes, candy and trick-or-treating. As families celebrate this season, Johns Hopkins Children’s Center experts are available for interviews on a variety of tips to help ensure a safe and fun Halloween.

Newswise: Blood Levels of ‘Free Range’ DNA May Signal Early Detection of Dementia and Frailty
Released: 11-Oct-2022 10:00 AM EDT
Blood Levels of ‘Free Range’ DNA May Signal Early Detection of Dementia and Frailty
Johns Hopkins Medicine

In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.

Newswise: Tip Sheet: Johns Hopkins Experts Present on Immigrant Mental Health, Reproductive Health Care and More at National Pediatrics Meeting
Released: 8-Oct-2022 8:00 AM EDT
Tip Sheet: Johns Hopkins Experts Present on Immigrant Mental Health, Reproductive Health Care and More at National Pediatrics Meeting
Johns Hopkins Medicine

Johns Hopkins Children’s Center researchers will present on several different topics at the AAP Experience National Conference & Exhibition.

Newswise: Researchers Find Link Between Immune Cells’ Closest Neighbors and Survival Time in Patients with Pancreatic Cancer
Released: 6-Oct-2022 1:00 PM EDT
Researchers Find Link Between Immune Cells’ Closest Neighbors and Survival Time in Patients with Pancreatic Cancer
Johns Hopkins Medicine

Researchers from Johns Hopkins Medicine have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and how long they survive.

Newswise: Study Advances Search for Biological Markers that Predict Risk of Postpartum Depression
Released: 4-Oct-2022 8:45 AM EDT
Study Advances Search for Biological Markers that Predict Risk of Postpartum Depression
Johns Hopkins Medicine

A federally-funded study led by Johns Hopkins Medicine researchers discovered that communication among cells is altered in pregnant women who go on to develop postpartum depression (PPD) after giving birth.

Newswise: Get Boosted: New Study Underscores Need for COVID-19 Booster Shots for Older Adults
Released: 29-Sep-2022 10:00 AM EDT
Get Boosted: New Study Underscores Need for COVID-19 Booster Shots for Older Adults
Johns Hopkins Medicine

In a study of more than 80 men and women from Baltimore, Maryland, Johns Hopkins researchers have added to evidence that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly among older adults.

Newswise: Immune Function Remodeled by Mitochondrial Shape
28-Sep-2022 8:00 AM EDT
Immune Function Remodeled by Mitochondrial Shape
Johns Hopkins Medicine

A new study focused on the immune system’s Th17 cells suggests that the shape and function of their mitochondria (the powerhouse of cells) is important in autoimmune and inflammatory disorders, such as multiple sclerosis.

Newswise: Researchers Identify Potential Biomarker to Distinguish Two Aggressive Types of Brain Tumors in Children
Released: 21-Sep-2022 10:00 AM EDT
Researchers Identify Potential Biomarker to Distinguish Two Aggressive Types of Brain Tumors in Children
Johns Hopkins Medicine

It may soon be possible to identify Group 4 medulloblastomas—the most common malignant brain tumor in children--from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, could lead to the development of better-targeted cancer treating drugs, according to investigators at the Johns Hopkins Kimmel Cancer Center.



close
0.32872